cyproterone acetate has been researched along with Bone Loss, Osteoclastic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gai, L; Gai, P; Jia, Y; Liu, Y; Shi, H; Wang, S; Yu, X; Zhang, M | 1 |
Balint-Perić, L; Beljić, T; Elliesen, J; Petrović, J; Prelević, GM | 1 |
Christiansen, C; Johansen, JS; Riis, BJ; Rødbro, P; Thomsen, K | 1 |
3 trial(s) available for cyproterone acetate and Bone Loss, Osteoclastic
Article | Year |
---|---|
Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women.
Topics: Absorptiometry, Photon; Adolescent; Adolescent Development; Bone and Bones; Bone Density; Bone Development; Bone Resorption; China; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Femur Neck; Humans; Lumbar Vertebrae; Medication Adherence; Patient Dropouts | 2012 |
Effect of two different progestins (cyproterone acetate and norgestrel), administered in a cyclical estradiol valerate regimen, on markers of bone turnover.
Topics: Alkaline Phosphatase; Bone and Bones; Bone Resorption; Calcium; Creatinine; Cyproterone Acetate; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Estradiol; Female; Humans; Hydroxyproline; Middle Aged; Norgestrel; Osteocalcin | 1994 |
Bone turnover in postmenopausal women after withdrawal of estrogen/gestagen replacement therapy.
Topics: Alkaline Phosphatase; Bone and Bones; Bone Resorption; Calcium-Binding Proteins; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Female; Humans; Hydroxyproline; Menopause; Middle Aged; Osteocalcin; Osteoporosis; Progesterone; Substance Withdrawal Syndrome | 1987 |